Impact of tumour volume on outcomes in patients with locally advanced non-small cell lung cancer receiving chemoradiotherapy and consolidation durvalumab
PTV emerged as an independent prognostic factor for PFS, suggesting its utility in risk stratification and individualized treatment planning.
Authors
- Antonin Lévy (ORCID: https://orcid.org/0000-0003-4798-8899)
- Pernelle Lavaud (ORCID: https://orcid.org/0000-0002-1286-5955)
- A. Botticella
- Mihaela Aldea
- Jérôme Gambini
- Kristi Beshiri
- Cécile Le Péchoux
- Vincent Legendre
Institutions
- Inserm (FR)
- Université Paris Cité (FR)
- Université Paris-Saclay (FR)
- Institut Gustave Roussy (FR)
- Sorbonne Paris Cité (FR)
- CEA Paris-Saclay (FR)
- Bicêtre Hospital (FR)
Publication Details
- Journal
- British Journal of Radiology
- Published
- 2026-03-15
- DOI
- https://doi.org/10.1093/bjr/tqag048
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00